2 citations
,
December 2021 in “F1000Research” Most people in South India lack knowledge about managing COVID-19 at home.
2 citations
,
October 2020 in “Journal of Pharmacy And Bioallied Sciences” Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.
2 citations
,
May 2020 in “JAAD case reports” Ruxolitinib can cause a delayed skin reaction on the nose.
1 citations
,
April 2025 in “Experimental Dermatology” Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.
1 citations
,
April 2024 in “JMIR AI” Long COVID sufferers face significant challenges that need more public awareness and support.
1 citations
,
March 2024 in “British Journal of Clinical Pharmacology” Dermatology drug use in Denmark mostly follows expected patterns, but further checks are needed for any misuse.
1 citations
,
August 2022 in “Piel” Certain skin symptoms in COVID-19 patients may indicate a more severe illness.
1 citations
,
May 2022 in “IntechOpen eBooks” Natural products might help treat COVID-19, but current drugs like hydroxychloroquine haven't worked.
1 citations
,
March 2022 in “F1000Research” Training programs are needed to improve home COVID-19 management practices.
1 citations
,
May 2017 in “InTech eBooks” The chapter explains common scalp conditions, including infections, infestations, and tumors.
1 citations
,
May 2016 in “Journal of Veterinary Diagnostic Investigation” Exotic lice infest 45% of California mule deer, with younger and selenium-deficient deer more vulnerable.
January 2026 in “International Journal of Molecular Sciences” Brimonidine is effective for reducing facial redness in skin conditions and has potential for broader dermatological uses.
December 2025 in “Brazilian Journal of Chemical Engineering” October 2025 in “Frontiers in Pharmacology” Arctium lappa L. might help treat immune-related skin diseases, but more research is needed.
January 2025 in “AAPS PharmSciTech” Transethosomes improve drug delivery through the skin and show promise for treating various conditions.
January 2025 in “Ciência Rural” Improper use of benzyl benzoate on a dog can cause severe skin reactions.
December 2024 in “IntechOpen eBooks” Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.
October 2023 in “Pharmacoepidemiology and Drug Safety” Most dermatology drugs in Denmark are used correctly, with few unusual patterns.
October 2023 in “Journal der Deutschen Dermatologischen Gesellschaft” Pregnancy can trigger severe rosacea, which may be treated with antibiotics and steroids, but there's no clear treatment guideline.
August 2023 in “Iranian Journal of Clinical Infectious Diseases” Most skin issues were due to COVID-19, with some caused by vaccines or treatments, and were categorized into five types.
May 2023 in “Experimental Dermatology” RCM and OCT are effective for diagnosing and monitoring hair-related skin diseases but lack standardized protocols and need more research.
Artemisia maritima L. has strong medicinal potential, especially for treating infections and inflammation.
February 2023 in “Vaccines” COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.
January 2023 in “IP International Journal of Comprehensive and Advanced Pharmacology” Ayurvedic Rasayan formulations like Chyawanprash may help manage post-COVID symptoms by boosting immunity.
May 2022 in “Journal of the Dermatology Nurses' Association” The convention highlighted the importance of comprehensive patient care and early diagnosis in dermatology.
January 2022 in “Faculty of 1000 Research Ltd” Training programs are needed to improve home COVID-19 management in Mangalore.
January 2022 in “Faculty of 1000 Research Ltd” Training programs are needed to improve home COVID-19 management and educate on vital sign monitoring and danger signs.
September 2020 in “Journal of Mind and Medical Sciences” Combining NdYag laser with pulsed light effectively treats rosacea with manageable side effects.
A medicine company has recalled a drug because it contained an unlisted blood pressure medication.
April 2018 in “Journal of Investigative Dermatology” CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.